Avanos Medical (AVNS) Other Non-Current Liabilities (2013 - 2026)

Avanos Medical has reported Other Non-Current Liabilities for 14 years, with the latest figure at $14.1 million in Q1 2026.

• Quarterly Other Non-Current Liabilities rose 213.33% year-over-year to $14.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $14.1 million (up 213.33% YoY) and the FY2025 annual result came in at $13.5 million, up 206.82% from the prior year.
• Other Non-Current Liabilities grew to $14.1 million in Q1 2026 per AVNS's latest filing, from $13.5 million in the prior quarter.
• Over five years, Other Non-Current Liabilities peaked at $28.0 million in Q1 2022 and troughed at $4.3 million in Q2 2025.
• A 5-year average of $14.9 million and a median of $14.1 million in 2026 frame the typical range for Other Non-Current Liabilities.
• The sharpest annual moves came in 2025 and 2026: Other Non-Current Liabilities tumbled 59.05% in 2025, then soared 213.33% in 2026.
• Over 5 years, Other Non-Current Liabilities stood at $20.5 million in 2022, then slumped by 51.22% to $10.0 million in 2023, then tumbled by 56.0% to $4.4 million in 2024, then soared by 206.82% to $13.5 million in 2025, then grew by 4.44% to $14.1 million in 2026.
• According to Business Quant data, Other Non-Current Liabilities over the past three periods registered $14.1 million, $13.5 million, and $20.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.